For instance, EZH2, the catalytic subunit of PRC2, is overexpressed in CML leukemia-initiating cells (LICs), and its depletion in LICs results in decreased capacity to form secondary leukemia upon transplantation in a murine model [189]. The gene discussed is EZH2; the disease is leukemia.